These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8168925)

  • 21. Arg-gingipain a DNA vaccine induces protective immunity against infection by Porphyromonas gingivalis in a murine model.
    Yonezawa H; Ishihara K; Okuda K
    Infect Immun; 2001 May; 69(5):2858-64. PubMed ID: 11292699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of specific antibody-secreting cells in salivary glands of BALB/c mice following parenteral or oral immunization with Porphyromonas gingivalis fimbriae.
    Kusumoto Y; Ogawa T; Hamada S
    Arch Oral Biol; 1993 May; 38(5):361-7. PubMed ID: 8101076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies on the induction of the humoral immune responses to Bacteroides gingivalis fimbrial antigen in mice].
    Shimauchi H
    Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):60-77. PubMed ID: 1983739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody responses in the lungs of mice following oral immunization with Salmonella typhimurium aroA and invasive Escherichia coli strains expressing the filamentous hemagglutinin of Bordetella pertussis.
    Guzmán CA; Brownlie RM; Kadurugamuwa J; Walker MJ; Timmis KN
    Infect Immun; 1991 Dec; 59(12):4391-7. PubMed ID: 1937797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
    Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T
    Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection and immune responses induced by attenuated Salmonella typhimurium UK-1 strains.
    Zhang X; Kelly SM; Bollen W; Curtiss R
    Microb Pathog; 1999 Mar; 26(3):121-30. PubMed ID: 10089152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.
    Huang Y; Hajishengallis G; Michalek SM
    Infect Immun; 2001 Apr; 69(4):2154-61. PubMed ID: 11254570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific lung mucosal and systemic immune responses after oral immunization of mice with Salmonella typhimurium aroA, Salmonella typhi Ty21a, and invasive Escherichia coli expressing recombinant pertussis toxin S1 subunit.
    Walker MJ; Rohde M; Timmis KN; Guzmán CA
    Infect Immun; 1992 Oct; 60(10):4260-8. PubMed ID: 1398937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral immunization with recombinant Streptococcus gordonii expressing porphyromonas gingivalis FimA domains.
    Sharma A; Honma K; Evans RT; Hruby DE; Genco RJ
    Infect Immun; 2001 May; 69(5):2928-34. PubMed ID: 11292708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: persistence and induction of humoral responses in rats.
    Redman TK; Harmon CC; Michalek SM
    Infect Immun; 1994 Aug; 62(8):3162-71. PubMed ID: 8039885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of monoclonal antibody and route of immunization on the humoral immune response against Porphyromonas gingivalis.
    Van Tilburg ML; Kozarov EV; Progulske-Fox A; Brady LJ
    Oral Microbiol Immunol; 2001 Jun; 16(3):153-62. PubMed ID: 11358537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization with the RgpA-Kgp proteinase-adhesin complexes of Porphyromonas gingivalis protects against periodontal bone loss in the rat periodontitis model.
    Rajapakse PS; O'Brien-Simpson NM; Slakeski N; Hoffmann B; Reynolds EC
    Infect Immun; 2002 May; 70(5):2480-6. PubMed ID: 11953385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcutaneous immunization with a 40-kDa outer membrane protein of Porphyromonas gingivalis induces specific antibodies which inhibit coaggregation by P. gingivalis.
    Maeba S; Otake S; Namikoshi J; Shibata Y; Hayakawa M; Abiko Y; Yamamoto M
    Vaccine; 2005 Mar; 23(19):2513-21. PubMed ID: 15752838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of immune T cells derived from mucosal or systemic tissue on host responses to Porphyromonas gingivalis.
    Katz J; Michalek SM
    Oral Microbiol Immunol; 1998 Apr; 13(2):73-80. PubMed ID: 9573797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sublingual vaccination with fusion protein consisting of the functional domain of hemagglutinin A of Porphyromonas gingivalis and Escherichia coli maltose-binding protein elicits protective immunity in the oral cavity.
    Yuzawa S; Kurita-Ochiai T; Hashizume T; Kobayashi R; Abiko Y; Yamamoto M
    FEMS Immunol Med Microbiol; 2012 Mar; 64(2):265-72. PubMed ID: 22066647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization with Porphyromonas gingivalis capsular polysaccharide prevents P. gingivalis-elicited oral bone loss in a murine model.
    Gonzalez D; Tzianabos AO; Genco CA; Gibson FC
    Infect Immun; 2003 Apr; 71(4):2283-7. PubMed ID: 12654858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced immune response to a dual-promoter anti-caries DNA vaccine orally delivered by attenuated Salmonella typhimurium.
    Jiang H; Hu Y; Yang M; Liu H; Jiang G
    Immunobiology; 2017 May; 222(5):730-737. PubMed ID: 28187901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human monoclonal antibody inhibits Porphyromonas gingivalis hemagglutinin activity.
    Kaizuka K; Hosogi Y; Hayakawa M; Shibata Y; Abiko Y
    J Periodontol; 2003 Jan; 74(1):38-43. PubMed ID: 12593594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune responses to Streptococcus sobrinus surface protein antigen A expressed by recombinant Salmonella typhimurium.
    Doggett TA; Jagusztyn-Krynicka EK; Curtiss R
    Infect Immun; 1993 May; 61(5):1859-66. PubMed ID: 8478075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety. II. Expression in avirulent Salmonella spp. for mucosal immunization.
    Schödel F; Kelly S; Tinge S; Hopkins S; Peterson D; Milich D; Curtiss R
    Adv Exp Med Biol; 1996; 397():15-21. PubMed ID: 8718577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.